Cargando…
Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy
The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the D...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345790/ https://www.ncbi.nlm.nih.gov/pubmed/30679447 http://dx.doi.org/10.1038/s41598-018-36031-w |
_version_ | 1783389625690095616 |
---|---|
author | Szantroch, Marta Bala, Aleksandra Rysz, Andrzej Żyłkowski, Jarosław Marchel, Andrzej |
author_facet | Szantroch, Marta Bala, Aleksandra Rysz, Andrzej Żyłkowski, Jarosław Marchel, Andrzej |
author_sort | Szantroch, Marta |
collection | PubMed |
description | The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the Department of Neurosurgery of the Medical University of Warsaw. The Wada test was conducted bilaterally on 118 patients (236 cases). In four cases, due to complications, the test was conducted only unilaterally, which resulted in a total of 240 cases. Those cases were further analysed for the presence of adverse events. In all cases, intracranial circulation angiography (via the transfemoral approach) was performed before memory and language testing. Of the 122 patients, adverse events were observed in 75 patients (61.4%). Serious complications were notably rare and observed only in two patients (1.6%): one patient had a carotid artery dissection, and the other had a pseudoaneurysm at the puncture site. Mild adverse events (e.g., shivers or pain of the eye) were highly common – we observed them in 71 patients (58%), but they were short-term and well-tolerated by the subjects. Two patients (1.6%) had a seizure during the Wada test. Most of the adverse events occurring during the Wada test with propofol were mild and short-lived. Considering a small risk of serious damage to health, this procedure can be perceived as a good method for assessing language and memory in a fraction of the epilepsy surgery candidates. |
format | Online Article Text |
id | pubmed-6345790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63457902019-01-29 Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy Szantroch, Marta Bala, Aleksandra Rysz, Andrzej Żyłkowski, Jarosław Marchel, Andrzej Sci Rep Article The aim of this study was to assess the type and frequency of adverse events during the Wada test conducted with propofol as an anaesthetic agent. In total, 122 patients with temporal lobe epilepsy underwent the Wada test with propofol between 2006 and 2016 as part of presurgical evaluation at the Department of Neurosurgery of the Medical University of Warsaw. The Wada test was conducted bilaterally on 118 patients (236 cases). In four cases, due to complications, the test was conducted only unilaterally, which resulted in a total of 240 cases. Those cases were further analysed for the presence of adverse events. In all cases, intracranial circulation angiography (via the transfemoral approach) was performed before memory and language testing. Of the 122 patients, adverse events were observed in 75 patients (61.4%). Serious complications were notably rare and observed only in two patients (1.6%): one patient had a carotid artery dissection, and the other had a pseudoaneurysm at the puncture site. Mild adverse events (e.g., shivers or pain of the eye) were highly common – we observed them in 71 patients (58%), but they were short-term and well-tolerated by the subjects. Two patients (1.6%) had a seizure during the Wada test. Most of the adverse events occurring during the Wada test with propofol were mild and short-lived. Considering a small risk of serious damage to health, this procedure can be perceived as a good method for assessing language and memory in a fraction of the epilepsy surgery candidates. Nature Publishing Group UK 2019-01-24 /pmc/articles/PMC6345790/ /pubmed/30679447 http://dx.doi.org/10.1038/s41598-018-36031-w Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Szantroch, Marta Bala, Aleksandra Rysz, Andrzej Żyłkowski, Jarosław Marchel, Andrzej Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title | Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title_full | Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title_fullStr | Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title_full_unstemmed | Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title_short | Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
title_sort | experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345790/ https://www.ncbi.nlm.nih.gov/pubmed/30679447 http://dx.doi.org/10.1038/s41598-018-36031-w |
work_keys_str_mv | AT szantrochmarta experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy AT balaaleksandra experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy AT ryszandrzej experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy AT zyłkowskijarosław experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy AT marchelandrzej experienceofadverseeventswithcerebralpropofoltestinginpatientswithdrugresistantepilepsy |